Literature DB >> 32518985

Pelvic Trauma: factors predicting arterial hemorrhage and the role of Angiography and preperitoneal pelvic packing.

Jagteshwar Sandhu1,2, Robert Abrahams3, Zoe Miller4, Shivank Bhatia4, Tanya L Zakrison5, Prasoon Mohan4.   

Abstract

OBJECTIVES: (1) To identify the factors predicting arterial extravasation in pelvic trauma and (2) to assess the efficacy of preperitoneal pelvic packing (PPP) in controlling arterial hemorrhage.
METHODS: Institutional review board approved the retrospective study of 139 consecutive pelvic trauma patients who underwent angiographic intervention with or without prior PPP between January 2011 and December 2016. Patient demographics and presenting characteristics were recorded. Both groups of patients were combined for analysis of predictors for arterial extravasation using univariate logistic regression followed by multivariate logistic regression. Significance level was defined as p < 0.05.
RESULTS: Forty-nine out of 139 patients had PPP prior to pelvic angiogram. Embolization was performed in 85 (61.2%) patients and the technical and clinical success rate was 100%. Sixty-nine (49.7%) patients had unstable Young-Burgess (Y&B) type fractures, of which 58% had arterial hemorrhage compared with 38.6% of those with stable Y&B fractures (p = 0.02). Of the patients who had PPP prior to angiogram, 28(57.1%) continued to have arterial extravasation on subsequent angiography. Unstable Y&B type fractures are independent predictors of arterial hemorrhage (OR 2.3, 95%CI 1.1 to 4.7, p = 0.02).
CONCLUSION: Unstable Y&B type pelvic fractures are predictors of arterial extravasation. PPP alone is not effective for arterial hemorrhage control in pelvic trauma. Angiographic intervention remains a minimally invasive and definitive treatment of arterial hemorrhage from pelvic trauma. KEY POINTS: • Unstable Young-Burgess pelvic fractures are predictors of arterial hemorrhage in pelvic trauma. • Pelvic angiography and embolization should precede PPP wherever feasible.

Entities:  

Keywords:  Angiography; Fracture; Hemorrhage; Pelvis; Trauma

Mesh:

Year:  2020        PMID: 32518985     DOI: 10.1007/s00330-020-06965-9

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  4 in total

Review 1.  Eastern Association for the Surgery of Trauma practice management guidelines for hemorrhage in pelvic fracture--update and systematic review.

Authors:  Daniel C Cullinane; Henry J Schiller; Martin D Zielinski; Jaroslaw W Bilaniuk; Bryan R Collier; John Como; Michelle Holevar; Enrique A Sabater; S Andrew Sems; W Matthew Vassy; Julie L Wynne
Journal:  J Trauma       Date:  2011-12

2.  Intra-aortic balloon occlusion to salvage patients with life-threatening hemorrhagic shocks from pelvic fractures.

Authors:  Thomas Martinelli; Frédéric Thony; Philippe Decléty; Christian Sengel; Christophe Broux; Jérôme Tonetti; Jean-François Payen; Gilbert Ferretti
Journal:  J Trauma       Date:  2010-04

3.  Percutaneous transcatheter embolization for massive bleeding from pelvic fractures.

Authors:  T Panetta; S J Sclafani; A S Goldstein; T F Phillips; G W Shaftan
Journal:  J Trauma       Date:  1985-11

Review 4.  Utility of simultaneous interventional radiology and operative surgery in a dedicated suite for seriously injured patients.

Authors:  Scott K D'Amours; Pratik Rastogi; Chad G Ball
Journal:  Curr Opin Crit Care       Date:  2013-12       Impact factor: 3.687

  4 in total
  2 in total

Review 1.  Endovascular Management of Pelvic Trauma.

Authors:  Husameddin El Khudari; Ahmed Kamel Abdel Aal
Journal:  Semin Intervent Radiol       Date:  2021-04-15       Impact factor: 1.513

Review 2.  Proposal of standardization of every step of angiographic procedure in bleeding patients from pelvic trauma.

Authors:  Matteo Renzulli; Anna Maria Ierardi; Nicolò Brandi; Sofia Battisti; Emanuela Giampalma; Giovanni Marasco; Daniele Spinelli; Tiziana Principi; Fausto Catena; Mansoor Khan; Salomone Di Saverio; Giampaolo Carrafiello; Rita Golfieri
Journal:  Eur J Med Res       Date:  2021-10-14       Impact factor: 2.175

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.